Literature DB >> 30028028

Nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (NOX) and liver fibrosis: A review.

Keywan Mortezaee1.   

Abstract

Nicotinamide adenine dinucleotide phosphate (NADPH) oxidases (NOXs) are key producer of reactive oxygen species in liver cells. Hepatic stellate cells (HSCs) and Kupffer cells (KCs) are the two key cells for expression of NOX in liver. KCs produce only NOX2, while HSCs produce NOX1, 2, and 4, all of which play essential roles in the process of fibrogenesis within liver. These NOX subtypes are contributed to induction of liver fibrosis by acting through multiple pathways including induction of HSC activation, proliferation, survival and migration, stimulation of hepatocyte apoptosis, enhancement of fibrogenic mediators, and mediation of an inflammatory cascade in both KCs and HSCs. SIGNIFICANCE: KCs and HSCs are two key cells for production of NOX in liver in relation to the pathology of liver fibrosis. NOX subtypes 1, 2, and 4 are inducers of fibrogenesis in liver. NOX activation favors hepatocyte apoptosis, HSC activation, and KC-mediated inflammatory cascade in liver, all of which are responsible for generation of liver fibrosis.
© 2018 John Wiley & Sons, Ltd.

Entities:  

Keywords:  Kupffer cells (KCs); fibrosis; hepatic stellate cells (HSCs); nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (NOX); reactive oxygen species (ROS)

Mesh:

Substances:

Year:  2018        PMID: 30028028     DOI: 10.1002/cbf.3351

Source DB:  PubMed          Journal:  Cell Biochem Funct        ISSN: 0263-6484            Impact factor:   3.685


  13 in total

Review 1.  Steps in metastasis: an updated review.

Authors:  Jamal Majidpoor; Keywan Mortezaee
Journal:  Med Oncol       Date:  2021-01-04       Impact factor: 3.064

Review 2.  NK and cells with NK-like activities in cancer immunotherapy-clinical perspectives.

Authors:  Keywan Mortezaee; Jamal Majidpoor
Journal:  Med Oncol       Date:  2022-06-18       Impact factor: 3.064

Review 3.  Key promoters of tumor hallmarks.

Authors:  Keywan Mortezaee; Jamal Majidpoor
Journal:  Int J Clin Oncol       Date:  2021-11-13       Impact factor: 3.402

Review 4.  Epithelial-mesenchymal transition in cancer stemness and heterogeneity: updated.

Authors:  Keywan Mortezaee; Jamal Majidpoor; Ebrahim Kharazinejad
Journal:  Med Oncol       Date:  2022-09-07       Impact factor: 3.738

Review 5.  Roles for macrophage-polarizing interleukins in cancer immunity and immunotherapy.

Authors:  Keywan Mortezaee; Jamal Majidpoor
Journal:  Cell Oncol (Dordr)       Date:  2022-05-19       Impact factor: 7.051

Review 6.  NADPH Oxidases Connecting Fatty Liver Disease, Insulin Resistance and Type 2 Diabetes: Current Knowledge and Therapeutic Outlook.

Authors:  Alberto Nascè; Karim Gariani; François R Jornayvaz; Ildiko Szanto
Journal:  Antioxidants (Basel)       Date:  2022-06-09

7.  Forsythiaside A Regulates Activation of Hepatic Stellate Cells by Inhibiting NOX4-Dependent ROS.

Authors:  Mengting Zhou; Xingtao Zhao; Li Liao; Ying Deng; Meichen Liu; Jing Wang; Xinyan Xue; Yunxia Li
Journal:  Oxid Med Cell Longev       Date:  2022-01-05       Impact factor: 6.543

8.  Ursolic acid reverses liver fibrosis by inhibiting NOX4/NLRP3 inflammasome pathways and bacterial dysbiosis.

Authors:  Yuan Nie; Qi Liu; Wang Zhang; Yipeng Wan; Chenkai Huang; Xuan Zhu
Journal:  Gut Microbes       Date:  2021 Jan-Dec

Review 9.  Gasotransmitters: Potential Therapeutic Molecules of Fibrotic Diseases.

Authors:  Yingqing Chen; Shuo Yuan; Yuying Cao; Guangyao Kong; Feng Jiang; You Li; Qi Wang; Minli Tang; Qinggao Zhang; Qianqian Wang; Liping Liu
Journal:  Oxid Med Cell Longev       Date:  2021-09-20       Impact factor: 6.543

10.  Role of Metabolism in Hepatic Stellate Cell Activation and Fibrogenesis.

Authors:  Wei Hou; Wing-Kin Syn
Journal:  Front Cell Dev Biol       Date:  2018-11-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.